Neurolixis Inc. is a biopharmaceutical company focused on the discovery and development of novel drugs for the treatment of human central nervous system diseases including movement disorders, autism spectrum disorders, depression and pain.

Neurolixis

Adrian Newman-Tancredi

This department is responsible for guiding the overall strategic direction and management of the organization.

Executive Leadership

This department focuses on advancing research in pharmacology and overseeing clinical development processes.

Neurolixis

Org chart

Teams

Executive Leadership

Pharmacology and Development

Offices

Neurolixis

Org chart

Teams

Executive Leadership

Pharmacology and Development

Offices

Related companies